Back to Search
Start Over
Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure
- Source :
- Marques, F Z, Prestes, P R, Byars, S G, Ritchie, S C, Würtz, P, Patel, S K, Booth, S A, Rana, I, Minoda, Y, Berzins, S P, Curl, C L, Bell, J R, Wai, B, Srivastava, P M, Kangas, A J, Soininen, P, Ruohonen, S, Kähönen, M, Lehtimäki, T, Raitoharju, E, Havulinna, A, Perola, M, Raitakari, O, Salomaa, V, Ala-Korpela, M, Kettunen, J, McGlynn, M, Kelly, J, Wlodek, M E, Lewandowski, P A, Delbridge, L M, Burrell, L M, Inouye, M, Harrap, S B & Charchar, F J 2017, ' Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure ', Journal of the American Heart Association, vol. 6, no. 6, e005971 . https://doi.org/10.1161/JAHA.117.005971, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
- Publication Year :
- 2017
-
Abstract
- Background Cardiac hypertrophy increases the risk of developing heart failure and cardiovascular death. The neutrophil inflammatory protein, lipocalin‐2 (LCN2/NGAL), is elevated in certain forms of cardiac hypertrophy and acute heart failure. However, a specific role for LCN2 in predisposition and etiology of hypertrophy and the relevant genetic determinants are unclear. Here, we defined the role of LCN2 in concentric cardiac hypertrophy in terms of pathophysiology, inflammatory expression networks, and genomic determinants. Methods and Results We used 3 experimental models: a polygenic model of cardiac hypertrophy and heart failure, a model of intrauterine growth restriction and Lcn2‐knockout mouse; cultured cardiomyocytes; and 2 human cohorts: 114 type 2 diabetes mellitus patients and 2064 healthy subjects of the YFS (Young Finns Study). In hypertrophic heart rats, cardiac and circulating Lcn2 was significantly overexpressed before, during, and after development of cardiac hypertrophy and heart failure. Lcn2 expression was increased in hypertrophic hearts in a model of intrauterine growth restriction, whereas Lcn2‐knockout mice had smaller hearts. In cultured cardiomyocytes, Lcn2 activated molecular hypertrophic pathways and increased cell size, but reduced proliferation and cell numbers. Increased LCN2 was associated with cardiac hypertrophy and diastolic dysfunction in diabetes mellitus. In the YFS, LCN2 expression was associated with body mass index and cardiac mass and with levels of inflammatory markers. The single‐nucleotide polymorphism, rs13297295, located near LCN2 defined a significant cis‐eQTL for LCN2 expression. Conclusions Direct effects of LCN2 on cardiomyocyte size and number and the consistent associations in experimental and human analyses reveal a central role for LCN2 in the ontogeny of cardiac hypertrophy and heart failure.<br />published version<br />peerReviewed
- Subjects :
- 0301 basic medicine
Male
SYSTEMIC INFLAMMATION
Translational Studies
MIR-15 FAMILY
Lipocalin
Systemic inflammation
Left ventricular hypertrophy
Rats, Inbred WKY
DISEASE
Muscle hypertrophy
Heart Failure/diagnosis
Mice
Pregnancy
GROWTH RESTRICTION
Myocytes, Cardiac
Prospective Studies
R PACKAGE
NGAL
Cells, Cultured
Original Research
2. Zero hunger
Mice, Knockout
INSULIN-RESISTANCE
biology
lipocalin-2
CARDIOVASCULAR RISK
systems biology
lipocalin‐2
Myocytes, Cardiac/metabolism
3. Good health
C‐reactive protein
Echocardiography
Cardiology
Female
medicine.symptom
Cardiology and Cardiovascular Medicine
hypertrophy
medicine.medical_specialty
Concentric hypertrophy
Cardiomegaly
RNA/genetics
C-reactive protein
03 medical and health sciences
Insulin resistance
Cardiomegaly/diagnosis
LEFT-VENTRICULAR HYPERTROPHY
Internal medicine
medicine
Genetics
Animals
Humans
Inflammation
Heart Failure
GlycA
business.industry
ta3121
medicine.disease
Rats
Mice, Inbred C57BL
030104 developmental biology
Endocrinology
Animal Models of Human Disease
Gene Expression Regulation
Heart failure
Lipocalin-2/biosynthesis
DIFFERENTIAL EXPRESSION ANALYSIS
3121 General medicine, internal medicine and other clinical medicine
YOUNG FINNS
biology.protein
RNA
Pregnancy, Animal
gene coexpression networks
business
Basic Science Research
Follow-Up Studies
concentric hypertrophy
Subjects
Details
- Language :
- English
- ISSN :
- 13297295
- Database :
- OpenAIRE
- Journal :
- Marques, F Z, Prestes, P R, Byars, S G, Ritchie, S C, Würtz, P, Patel, S K, Booth, S A, Rana, I, Minoda, Y, Berzins, S P, Curl, C L, Bell, J R, Wai, B, Srivastava, P M, Kangas, A J, Soininen, P, Ruohonen, S, Kähönen, M, Lehtimäki, T, Raitoharju, E, Havulinna, A, Perola, M, Raitakari, O, Salomaa, V, Ala-Korpela, M, Kettunen, J, McGlynn, M, Kelly, J, Wlodek, M E, Lewandowski, P A, Delbridge, L M, Burrell, L M, Inouye, M, Harrap, S B & Charchar, F J 2017, ' Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure ', Journal of the American Heart Association, vol. 6, no. 6, e005971 . https://doi.org/10.1161/JAHA.117.005971, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
- Accession number :
- edsair.doi.dedup.....22d103192332afee719e450d9adc746d
- Full Text :
- https://doi.org/10.1161/JAHA.117.005971